Verified · 2 outletsBusiness
Wegovy Reduces BMI in Kids With Obesity as Young as 6
Headline via MedPage Today · first report 16 Nov, 20:30 IST, latest 17 Nov, 03:17 IST
What we know
2 independent news organisations have reported this story. The first report we saw came from CNBC at 16 Nov, 20:30 IST; the latest is from MedPage Today at 17 Nov, 03:17 IST. Rational Times has not independently confirmed the details: read each report through the links below.
StatusVerified
Reported by2 news organisations
First report16 Nov, 20:30 IST
Latest report17 Nov, 03:17 IST
DeskBusiness
What the reports sayEach newsroom’s own summary of its report, from its feed
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
(MedPage Today) -- NATIONAL HARBOR, Md. -- Young children ages 6 to 11 years with obesity lost significant weight with the GLP-1 medication semaglutide (Wegovy), according to results from the phase III STEP Young trial. At week 68, mean body...
Quoted from the newsrooms’ own feeds, with their names and links. Rational Times has not independently confirmed the details.
The reports2 reports
- CNBC Novo says Wegovy injection lowers BMI and obesity rates in children in trial
- MedPage Today Wegovy Reduces BMI in Kids With Obesity as Young as 6
Headlines belong to the news organisations named; each links to their own report. We group reports automatically by their key words, so now and then two different stories can be grouped together, or one story split in two. Tell us about a mistake
Rational






